We closely monitor the latest research and regulatory guidance regarding novel therapies such as BPC-157
The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 ( Table 2 Clinical studies elucidating the use of antidiabetics against glaucoma
Lehner R, Lian J, Quiroga A
Rarely, higher doses or medication interactions may lead to more serious side effectsanother reason why consultation is key
Its crucial to follow the instructions provided by the manufacturer and consult with a healthcare professional before starting any new supplement regimen, especially if you have underlying health conditions or are taking other medications